Medtronic Starts First Human Study of Endurant Stent Graft System

Marking a major step toward expanding minimally invasive endovascular therapies, Medtronic, Inc. announced the start of the first human study of its Endurant Stent Graft System, an investigational treatment for abdominal aortic aneurysm.
ad-hoc-news